The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…
On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…
On Jul. 20, 2020, interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed…
On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…
On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…
On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…
On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced accepted an Indefinite Delivery Indefinite Quantity contract…
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…
On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPᆴ…
On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…
On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…
On Jul. 18, 2020, the FDA reissued an emergency use authorization (EUA) to Quest Diagnostics to authorize its…
On Jul. 18, 2020, a Health Trendsル study from researchers at Quest Diagnostics and the University of Pittsburgh…
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…
On Jul. 16, 2020, Catalent and Humanigen announced the expansion of their relationship, under which Catalent will provide…
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…
On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…
On Jul. 15, 2020, in collaboration with the Guangdong CDC, Hunan CDC, Sun Yat-Sen University and Southeast University,…
On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…
On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinメs Office of the…
On Jul. 14, 2020, a study by NIH researchers reported the placental membranes that contain the fetus and…
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the NIIH, announced…
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…